Lv11
70 积分 2022-12-22 加入
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
2个月前
已完结
Biomarkers for immunotherapy of hepatocellular carcinoma
2个月前
已完结
Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
2个月前
已完结
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
2个月前
已完结
Correction: A multitask deep learning radiomics model for predicting the macrotrabecular‑massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy
2个月前
已完结
MRI-based Nomogram Predicts the Risk of Progression of Unresectable Hepatocellular Carcinoma After Combined Lenvatinib and anti-PD-1 Antibody Therapy
2个月前
已完结
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
2个月前
已完结
Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma
2个月前
已完结
Sorafenib in Advanced Hepatocellular Carcinoma
8个月前
已完结
MRI‐Based Radiomics and Deep Learning in Biological Characteristics and Prognosis of Hepatocellular Carcinoma: Opportunities and Challenges
8个月前
已完结
皖公网安备34019202002308
